US Patent 10947270 Targeted prodrug cytosine deaminase fusion carrier and application thereof
Patent 10947270 was granted and assigned to National Yang-Ming University on March, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10947270 Targeted prodrug cytosine deaminase fusion carrier and application thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.